Considerations for the use of plasma cytokeratin 18 as a biomarker in pancreatic cancer.

Br J Cancer · 2010 · PMC2822934 · PMID 20051949

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

failed to reach significanceno p-value reported

In keeping with the other malignant tumour types ( Ulukaya et al , 2007 ; Hou et al , 2009 ; Koelink et al , 2009 ), elevated CK18 levels were associated with poorer survival in the overall patient group on univariate analysis, but in this series failed to reach significance on multivariate analysis.

also in 4,113 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.